Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update on JIML

5 May 2026 07:00

RNS Number : 9084C
Jarvis Securities plc
05 May 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update on JIML

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, (the "Transaction"). In order to deliver optimal value for shareholders, the Company has engaged S&W Partners LLP to explore the possibility of a sale of JIML. (the "Potential Disposal"). The Potential Disposal will be subject to conditions set out below and there can be no certainty as to the timing of the Potential Disposal or that it will occur at all.

After the Transaction, the termination of the Model B clearing and settlement services and the wind down of the associated operations (as further detailed in the Announcement) the assets presently remaining in JIML (which has permissions to undertake regulated activities and hold client assets) are:

i. approximately 1,800 clients with assets under administration of circa £44 million (including circa £7 million of potentially illiquid and/or non-returnable client assets), although this is declining as assets are withdrawn;

ii. the right to receive any deferred consideration due from the Transaction;

iii. any remaining cash balances; and 

iv. the group's intellectual property (which includes the "X-O" and "Sharedeal Active" trademarks).

 

It should be noted that any proposed sale of JIML's shares and any associated change of control would be subject to, the FCA's consent. 

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis - C/O S&W Partners LLP - 0204 617 55 00 (Phil Hemming (Phil.hemming@swgroup.com) / Christopher Samson (Samson.christopher@swgroup.com))

 Zeus Capital (Nominated Adviser) - 020 3829 5000 (Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAKQBDFBKDAPK
Date   Source Headline
8th Nov 20173:45 pmRNSDividend Declaration
7th Nov 20174:20 pmRNSTotal Voting Rights
1st Sep 20177:00 amRNSTransaction in Own Shares
29th Aug 201712:09 pmRNSDirectors' Interests
4th Aug 201711:00 amRNSDividend Declaration
31st Jul 20172:14 pmRNSDirectors' interests
20th Jul 20177:00 amRNSInterim Results - Six Months End 30 June 2017
24th May 20172:50 pmRNSNotification of Major Interest in Shares
11th May 20177:00 amRNSDividend Declaration and Trading Statement
4th May 20177:00 amRNSExercise of options
24th Apr 20173:28 pmRNSEXERCISE OF OPTIONS AND TRANSACTION IN OWN SHARES
21st Apr 20171:07 pmRNSPDMR Dealings
10th Apr 20174:55 pmRNSDirectors' Interests
23rd Mar 20171:45 pmRNSResult of Annual General Meeting
16th Mar 20177:00 amRNSExercise of options
28th Feb 201710:20 amRNSExercise of options
16th Feb 20177:00 amRNSFinal Results
6th Feb 20173:34 pmRNSDividend Declaration
6th Jan 20177:00 amRNSDirector/PDMR Shareholding
28th Nov 201611:30 amRNSExercise of options
8th Nov 20161:19 pmRNSDividend Declaration
7th Sep 20168:43 amRNSDirectors' Interests & Transaction in Own Shares
6th Sep 201612:48 pmRNSDirector/PDMR Shareholding
2nd Aug 201610:50 amRNSTransaction in Own Shares
21st Jul 20167:00 amRNSHalf-year Report
8th Jul 201610:34 amRNSDividend Declaration
7th Jul 20168:13 amRNSHolding(s) in Company
3rd Jun 20163:22 pmRNSHolding(s) in Company
3rd Jun 20167:00 amRNSTransaction in Own Shares
18th May 20167:00 amRNSExecution of Heads of Terms
10th May 201611:34 amRNSDividend Declaration
31st Mar 20164:18 pmRNSDirectors' Interests
24th Mar 201611:45 amRNSResult of AGM
18th Mar 20163:07 pmRNSDirector/PDMR Shareholding
15th Mar 20169:35 amRNSDirector/PDMR Shareholding
14th Mar 201612:02 pmRNSDirector/PDMR Shareholding
10th Mar 20167:00 amRNSTransaction in Own Shares
3rd Mar 201611:31 amRNSReplacement - Transaction in Own Shares
3rd Mar 20167:00 amRNSTransaction in Own Shares
25th Feb 201611:59 amRNSDirector/PDMR Shareholding
22nd Feb 201610:01 amRNSDirector/PDMR Shareholding
18th Feb 201612:33 pmRNSTransaction in Own Shares
18th Feb 20167:00 amRNSFinal Results
9th Feb 20169:51 amRNSDividend Declaration
9th Dec 20157:00 amRNSTransaction in Own Shares
12th Nov 20157:00 amRNSDividend Declaration
28th Aug 20153:38 pmRNSTransaction in Own Shares
10th Aug 201512:57 pmRNSTransaction in Own Shares
24th Jul 20157:00 amRNSDividend Declaration
23rd Jul 20157:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.